title: Development of a clinically significant ADAMTS13 inhibitor in a patient with hereditary thrombotic thrombocytopenic purpura.
authors.affiliation: The Institute for Transfusion Medicine, Pittsburgh, Pennsylvania; Department of Pathology, University of Pittsburgh, Pittsburgh, Pennsylvania.
authors.forename: Jay S
authors.initials: JS
authors.lastname: Raval
authors.forename: Anand
authors.initials: A
authors.lastname: Padmanabhan
authors.forename: Johanna A
authors.initials: JA
authors.lastname: Kremer Hovinga
authors.forename: Joseph E
authors.initials: JE
authors.lastname: Kiss
mesh_terms: D051722:ADAM Proteins / Q000037:antagonists & inhibitors* / Q000235:genetics; D000071120:ADAMTS13 Protein; D000328:Adult; D005260:Female; D006801:Humans; D009154:Mutation; D010951:Plasma Exchange / Q000009:adverse effects; D011697:Purpura, Thrombotic Thrombocytopenic / Q000201:enzymology / Q000235:genetics / Q000628:therapy; D016896:Treatment Outcome
chemical_list: D051722:ADAM Proteins; D000071120:ADAMTS13 Protein; C099604:ADAMTS13 protein, human